Finolex is India’s second-largest pipe maker and third-largest PVC resin producer, but lately it feels more like a B-grade Bollywood sequel—big name, weak script. PVC resin revenues collapsed 83% thanks to global price meltdowns, leaving pipes & fittings to carry 99% of the load. The market still values it at ₹13,000 Cr with a lofty 35x P/E, but sales growth is negative, margins are volatile, and management changes are as frequent as Bigg Boss contestants.
2. Introduction
There was a time when the Finolex name was synonymous with cables, pipes, and “TV ads with farmers holding blue pipes smiling into the sunset.” Fast-forward to FY25, and the company is a pure-play pipes & fittings business with a resin side hustle that’s mostly an internal transfer game.
In theory, backward integration should be a masterstroke—make your own resin, save on raw material costs. In practice, resin prices crashed so badly that Finolex’s resin division went from hero to zero. Over FY22–FY24, resin revenues declined ~83%. It’s like making your own mangoes but realizing the mandi rate has fallen to onion levels.
Pipes remain the star child. With over 2,000 SKUs, Finolex caters to everything from farmer borewells to swanky CPVC bathroom fittings. The company has been shouting about shifting focus from agri (40% share) to non-agri (50% target in 3–4 years). Translation: “Farmers, we still love you, but urban bathrooms pay better.”
3. Business Model – WTF Do They Even Do?
Finolex makes PVC pipes. Lots of them. Big ones for fields, slim ones for bathrooms, thick ones for sewage. If there’s water to be moved, they’ve got a pipe for it.
The resin business? Mostly feeding its own pipe plants, like cooking your own rice for dinner rather than buying biryani. Almost 90% of resin sales are captive transfers. With resin volumes collapsing to 2,680 MT in H1 FY25 (vs 14,000+ MT in FY24), the division is basically a rounding error.
Distribution is solid—900 dealers, 30,000 retailers, and offices in every city where real estate developers pretend to be visionaries. Production capacity is impressive too: 4.7 lakh MT pipes and 2.7 lakh MT resin, though utilization hovers in the 70% range.
Future growth bets: add 40,000–50,000 MT capacity in FY25, push non-agri, and hopefully ride out resin volatility. But is the strategy working, or are they just laying more pipelines to nowhere?
4. Financials Overview
Quarterly Snapshot (₹ Cr):
Metric
Latest Qtr (Jun’25)
YoY Qtr (Jun’24)
Prev Qtr (Mar’25)
YoY %
QoQ %
Revenue
1,043
1,140
1,172
-8.5%
-11.0%
EBITDA
94
207
171
-55%
-45%
PAT
97
505*
150
-81%
-35%
EPS (₹)
1.56
8.14*
2.42
-81%
-36%
*Jun’24 PAT included an exceptional income gain—don’t get too excited.
Commentary: Annualized EPS ~₹6. At CMP ₹211, that’s a P/E of 35x. Supreme Industries trades at 63x, Astral at 81x. Expensive peers, sure, but they deliver growth. Finolex? Just delivering excuses.
5. Valuation – Fair Value Range Only
P/E Method:
EPS (TTM): ₹5.96
Apply range 20x–25x (sector mean vs growth quality)
Fair Value = ₹120 – ₹150
EV/EBITDA Method:
EV: ₹13,177 Cr, EBITDA: ₹620 Cr → 21x
Apply 15–18x → EV fair range: ₹9,300 – ₹11,200 Cr
Equity Value/share: ₹150 – ₹180
DCF Quick Cut:
FCF (TTM): ~₹225 Cr
Growth: 5%, Terminal: 3%, WACC: 11%
Value range: ₹11,000 – ₹12,500 Cr → Per share: ₹175 – ₹200
Fair Value Range: ₹150 – ₹200
Disclaimer: Educational purposes only. Not investment advice.
6. What’s Cooking – News, Triggers, Drama
Management Churn: New MD Udipt Agarwal taking charge Nov 2025. Old MDs resigning faster than students after mid-sem exams.
Exceptional Gains: Q1 FY26 profit got a ₹417 Cr boost from one-off income. Strip it out, and the numbers look
